Researchers have used liver biopsies to identify cellular and molecular markers that can potentially be used to predict whether and when pancreatic cancer will spread to an individual’s liver or elsewhere, such as the lung.
The study, published in Nature Medicine, proposes that information from a liver biopsy—a small tissue sample collected for lab analysis—when pancreatic cancer is diagnosed may help guide doctors in personalizing treatment, such as liver-directed immunotherapies, before cancer cells have the chance to metastasize.
Only 10 percent of people with pancreatic cancer will survive more than two years after initial diagnosis. “If we can predict the timing and location of metastases, that could be a real game changer in treating pancreatic cancer, particularly patients at high metastatic risk,” said the study co-senior author.
In 2015, the authors discovered that pancreatic cancer cells secrete factors that reach distant organs, most often the liver, to establish a pre-metastatic niche for new tumors to form.
They obtained liver biopsies from 49 individuals who underwent surgical treatment for early-stage pancreatic cancer. They also collected liver biopsies from 19 people who underwent a similar operation for conditions unrelated to cancer, for example, removal of benign pancreatic cysts.
The researchers then conducted a battery of molecular, cellular and metabolic analyses on these samples to determine whether they could identify hallmarks that preceded—or potentially prevented—subsequent metastases in the patients. They found that the livers of recurrence-free survivors, who showed no signs of cancer spread after a follow-up period of at least three years, looked much like the livers of people who never had cancer.
At the other end of the spectrum were those who developed liver metastases within six months of diagnosis—a patient group that has poor prognosis with limited therapeutic options. Their livers were riddled with so-called neutrophil extracellular traps (NETs), dense tangles of DNA and enzymes released by dying neutrophils, immune cells that are a first line of defense against infection. Because these NETs are strongly associated with future metastases and develop so early in the course of disease, radiological imaging in the near future may be able to detect them and identify patients in danger of this aggressive spread.
“These individuals could then receive a full course of chemotherapy or, if the metastases are detected when only a few appear, perhaps the secondary tumors could be surgically removed,” said the author. In addition, the authors are investigating whether drugs that digest the DNA which forms the NETs could prevent liver metastases.
The researchers identified two other categories of patients in the study: those who would go on to develop later metastases to the liver and those who would have the cancer spread to other sites, such as the lung. Patients whose cancers spread to organs other than the liver, showed a strong immune response fighting the cancer—protective T cells and natural killer cells had infiltrated their livers, and many immune-regulatory genes were activated. These individuals who are prone to developing metastases outside the liver may benefit from immunotherapy to boost their ongoing anti-tumor immune response.
On the flip side, those whose livers succumbed to later metastases also accumulated immune cells—but the cells showed signs of metabolic exhaustion. “It’s as if the liver was trying to protect itself, but lost the battle in the end,” said the author.
The researchers plan to validate their findings in a larger cohort of patients with pancreatic cancer and examine if this approach could be useful with other newly diagnosed cancers. “We hope to develop a tool for predicting which patients with colorectal cancer will go on to develop liver metastases based on the cellular, molecular and metabolic profiles of their liver biopsies,” said another co-senior author.
https://www.nature.com/articles/s41591-024-03075-7
Liver biopsy to predict pancreatic cancer metastasis
- 223 views
- Added
Edited
Latest News
How our brain reacts to and…
By newseditor
Posted 08 Jul
Tissue-specific gene regula…
By newseditor
Posted 07 Jul
How hippocampus is activate…
By newseditor
Posted 07 Jul
Removal of excess chloride…
By newseditor
Posted 07 Jul
Intermittent fasting and br…
By newseditor
Posted 07 Jul
Other Top Stories
Single brain region links depression and anxiety, heart disease, an…
Read more
Why are some COVID-19 infected people asymptomatic?
Read more
How a common mutation leads to sleep disorder
Read more
Brainstem neuronal gene expression controls both behaviour and misb…
Read more
How the brain manages to adapt without a corpus callosum
Read more
Protocols
Pan-cancer proteogenomics c…
By newseditor
Posted 05 Jul
A systems biology-based ide…
By newseditor
Posted 05 Jul
Tongue orthotopic xenograft…
By newseditor
Posted 04 Jul
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Publications
Body Composition in Advance…
By newseditor
Posted 08 Jul
Spatiotemporal brain hierar…
By newseditor
Posted 08 Jul
HNF4A and HNF1A exhibit tis…
By newseditor
Posted 07 Jul
The hippocampus dissociates…
By newseditor
Posted 07 Jul
Downregulation of the silen…
By newseditor
Posted 07 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar